Dupilumab for chronic spontaneous urticaria-marvelous or meek?

Mathur, Sameer K; Rosenberg, Daniel L; Viswanathan, Ravi K

Mathur, Sameer K; Rosenberg, Daniel L; Viswanathan, Ravi K.

Afiliación

Mathur SK; Division of Allergy, Pulmonary, and Critical Care, Department of Medicine, School of Medicine and Public Health, University of Wisconsin-Madison, Madison, Wis. Electronic address: skmathur@wisc.edu.
Rosenberg DL; Division of Allergy, Pulmonary, and Critical Care, Department of Medicine, School of Medicine and Public Health, University of Wisconsin-Madison, Madison, Wis.
Viswanathan RK; Division of Allergy, Pulmonary, and Critical Care, Department of Medicine, School of Medicine and Public Health, University of Wisconsin-Madison, Madison, Wis.

J Allergy Clin Immunol ; 154(1): 91-93, 2024 Jul.

Article en En | MEDLINE | ID: mdl-38754637

Asunto(s)

Anticuerpos Monoclonales Humanizados; Urticaria Crónica; Humanos; Anticuerpos Monoclonales Humanizados/uso terapéutico; Urticaria Crónica/tratamiento farmacológico

Palabras clave

Urticaria; dupilumab; omalizumab

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Anticuerpos Monoclonales Humanizados / Urticaria Crónica Límite: Humans Idioma: En Revista: J Allergy Clin Immunol Año: 2024 Tipo del documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google